Understanding the role of small, soluble aggregates of beta-amyloid (Aβ) and tau in Alzheimer’s disease (AD) is of great importance for the rational design of preventative therapies. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.